IgA deficiency during D-penicillamine treatment.
نویسندگان
چکیده
منابع مشابه
Polymyositis complicating D-penicillamine treatment.
Although there is good evidence that D-penicillamine can induce polymyositis, the exact pathogenic mechanism remains unclear. We report two patients with psoriatic arthritis and primary biliary cirrhosis respectively, who developed polymyositis while receiving D-penicillamine treatment for their primary diseases. Whether D-penicillamine treatment was the sole cause of polymyositis or acted as a...
متن کاملIgA deficiency during treatment of infantile hypothyroidism with thyroxine.
Serum IgA concentrations in five children with infantile hypothyroidism fell soon after the start of treatment with thyroxine. In one child the IgA concentration fell appreciably (to less than 0.01 g/1) and remained reduced; in the four others it returned to normal. IgM and IgG concentrations were roughly normal throughout. The deficiency in IgA concentrations may have been due to stimulation b...
متن کاملWilson's disease: assessment of D-penicillamine treatment.
Serum copper and zinc concentrations and 24 hour urinary copper and zinc excretion were determined serially from the beginning of treatment with D-penicillamine in four children with Wilson's disease. The data show a progressive decrease in both serum copper and zinc concentrations in all. Urinary copper excretion gradually levelled off to approximately 50% of initial values, but zinc excretion...
متن کاملTreatment of scleroderma heart by D-penicillamine.
A case of severe diffuse systemic sclerosis with cardiomegaly and cardiac failure is described. Treatment with D-penicillamine caused a pronounced decrease in heart size, together with clinical improvement. The use of penicillamine in scleroderma heart has not previously been reported.
متن کاملMetal mediated bilirubin encephalopathy: Treatment with D-Penicillamine
Introduction Our recently published case reports and other healthy and highly educated patients of the long-term (28-42 years) follow-up suggest that D-Penicillamine (D-PA) therapy of newborn infants may have significant neuroprotective effects in cases jeopardized by bilirubin induced neurologic dysfunction (BIND) or retinopathy of prematurity (ROP) [1-3]. The first patient (43 ys) is now a me...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1977
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.1.6060.549